Aging Physiology and Pathophysiology
Aging physiology and pathophysiology is the study of how the structure and function of the human body change over the life course, and how those changes increase vulnerability to disease, disability, and death. It distinguishes intrinsic, time-dependent biological processes from the diseases that accumulate with age, and it provides the mechanistic foundation for geriatric medicine.
Definition
Aging is the progressive, time-dependent decline in physiological integrity and function that follows reproductive maturity, accompanied by reduced adaptive capacity and a rising risk of disease and death; its pathophysiology concerns how these changes translate into clinical vulnerability.
Scope
This area orients the reader to aging as a biological and clinical phenomenon: the molecular and cellular processes that drive it, the changes it produces across organ systems, the loss of physiologic reserve and homeostatic capacity it entails, and the role of cellular senescence and immune aging. It frames aging as a reference subject within geriatric medicine and does not provide individualized clinical guidance.
Sub-topics
Core questions
- What distinguishes normal (intrinsic) aging from age-related disease?
- Which molecular and cellular processes are common drivers of the aging phenotype?
- How do age-related changes in different organ systems reduce overall physiologic reserve?
- Why does vulnerability to stressors increase disproportionately in late life?
Key concepts
- Intrinsic aging versus age-related disease
- Physiologic reserve and its decline
- Homeostasis and homeostenosis
- Cellular senescence
- Immunosenescence and inflammaging
- Frailty as a clinical expression of biological aging
Key theories
- Hallmarks of aging framework
- A widely used organizing scheme that groups the drivers of aging into interconnected hallmarks (such as genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem-cell exhaustion, and altered intercellular communication), each meant to manifest with age, accelerate aging when worsened, and slow it when ameliorated.
- Geroscience hypothesis
- The proposal that the biological processes of aging are a shared upstream driver of many chronic diseases, so that targeting aging mechanisms could delay multiple age-related conditions together rather than one at a time.
Mechanisms
Aging arises from the accumulation of molecular and cellular damage that outpaces repair, producing genomic instability, telomere shortening, epigenetic drift, impaired protein homeostasis, mitochondrial dysfunction, and the build-up of senescent cells. These primary processes degrade tissue function and alter how cells communicate, including a shift toward chronic low-grade inflammation. The net effect across organ systems is a narrowing of the gap between baseline function and the threshold for failure, so that smaller perturbations are enough to cause clinical decline. The same mechanisms are proposed to act as common upstream contributors to many age-related diseases.
Clinical relevance
Understanding aging physiology explains why older adults present atypically, recover more slowly, and tolerate stressors less well than younger patients, and why several chronic diseases tend to cluster in late life. It is a reference foundation for geriatric assessment and for interpreting how physiologic reserve shapes outcomes; it describes biological processes and is not a basis for individual diagnostic or treatment decisions.
Epidemiology
Population aging is a global demographic trend, and the burden of age-related chronic disease, multimorbidity, and frailty rises steeply with chronological age. Chronic low-grade inflammation associated with aging is recognized as a contributor to morbidity and mortality across the later life span.
History
Biogerontology emerged as a distinct science in the twentieth century. Hayflick and Moorhead's 1961 demonstration that normal human cells have a finite replicative capacity reframed aging as a cell-intrinsic process rather than purely a matter of wear. Later decades brought molecular accounts of telomeres, senescence, and damage accumulation, culminating in integrative frameworks such as the hallmarks of aging and the geroscience hypothesis that connect basic aging biology to clinical disease.
Key figures
- Leonard Hayflick
- Carlos López-Otín
- Judith Campisi
- Linda Fried
- Claudio Franceschi
Related topics
Seminal works
- lopezotin-2013
- lopezotin-2023
- fried-2001
Frequently asked questions
- Is aging itself a disease?
- Aging is generally treated as a biological process rather than a disease: it is the progressive decline in physiological function and adaptive capacity that raises the risk of many diseases. The distinction between intrinsic aging and the specific diseases that accumulate with age is a central theme of this area, though the boundary is debated.
- What is the difference between physiology and pathophysiology of aging?
- The physiology of aging describes the normal, expected changes in body structure and function over time, while the pathophysiology of aging concerns how those changes translate into vulnerability, disease, and loss of function.